149 related articles for article (PubMed ID: 29956808)
21. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
[No Abstract] [Full Text] [Related]
22. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo.
Sun X; Zheng G; Li C; Liu C
Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133
[TBL] [Abstract][Full Text] [Related]
23. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
24. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
[TBL] [Abstract][Full Text] [Related]
25. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
[TBL] [Abstract][Full Text] [Related]
26. Circ_0000105 promotes liver cancer by regulating miR-498/PIK3R1.
Sun Y; Sun X; Huang Q
J Gene Med; 2020 Nov; 22(11):e3256. PubMed ID: 32729955
[TBL] [Abstract][Full Text] [Related]
27. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest.
Fan J; Lou B; Chen W; Zhang J; Lin S; Lv FF; Chen Y
Tumour Biol; 2014 Nov; 35(11):11523-32. PubMed ID: 25129440
[TBL] [Abstract][Full Text] [Related]
30. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
Zhang S; Li J; Wang X
Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
[TBL] [Abstract][Full Text] [Related]
31. TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53.
Yang J; Wang B; Xu Q; Yang Y; Hou L; Yin K; Guo Q; Hua Y; Zhang L; Li Y; Zhang J; Li N
Mol Cell Biochem; 2021 Feb; 476(2):1151-1163. PubMed ID: 33200377
[TBL] [Abstract][Full Text] [Related]
32. RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.
Mason JM; Dusad K; Wright WD; Grubb J; Budke B; Heyer WD; Connell PP; Weichselbaum RR; Bishop DK
Nucleic Acids Res; 2015 Mar; 43(6):3180-96. PubMed ID: 25765654
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
34. miR-346 Promotes HCC Progression by Suppressing Breast Cancer Metastasis Suppressor 1 Expression.
Guo Z; Li J; Sun J; Sun L; Zhou Y; Yu Z
Oncol Res; 2018 Aug; 26(7):1073-1081. PubMed ID: 29295726
[TBL] [Abstract][Full Text] [Related]
35. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to DNA damage caused by abrogation of Rad54 homolog B: A putative mechanism for chemically induced cleft palate.
Qiao W; Huang P; Wang X; Meng L
Toxicology; 2021 May; 456():152772. PubMed ID: 33823233
[TBL] [Abstract][Full Text] [Related]
37. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
38. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
40. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
